Following Tom Price's resignation as Department of Health & Human Services Secretary, President Trump has nominated ex-pharma exec Alex Azar as the HHS head. Azar spent 10 years at Eli Lilly, but was also HHS general counsel and deputy secretary previously, press reports say. Azar is reportedly critical of the Affordable Care Act and favors converting Medicaid to block grants.